vs
Side-by-side financial comparison of AlTi Global, Inc. (ALTI) and ORTHOPEDIATRICS CORP (KIDS). Click either name above to swap in a different company.
AlTi Global, Inc. is the larger business by last-quarter revenue ($86.6M vs $61.6M, roughly 1.4× ORTHOPEDIATRICS CORP). AlTi Global, Inc. runs the higher net margin — -15.1% vs -16.4%, a 1.3% gap on every dollar of revenue. On growth, AlTi Global, Inc. posted the faster year-over-year revenue change (87.0% vs 17.0%). ORTHOPEDIATRICS CORP produced more free cash flow last quarter ($9.7M vs $-52.2M). Over the past eight quarters, AlTi Global, Inc.'s revenue compounded faster (30.6% CAGR vs 17.4%).
Cristal Global is the world's second-largest producer of titanium dioxide and a leading producer of titanium chemicals. It was formed when The National Titanium Dioxide Company Ltd. combined with Millennium Chemicals. The headquarters are in Jeddah, Saudi Arabia. It is a significant shareholder in Bemax, the world’s 5th largest TiO2 feedstock producer.
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
ALTI vs KIDS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $86.6M | $61.6M |
| Net Profit | $-13.1M | $-10.1M |
| Gross Margin | — | 73.2% |
| Operating Margin | -2.1% | -13.3% |
| Net Margin | -15.1% | -16.4% |
| Revenue YoY | 87.0% | 17.0% |
| Net Profit YoY | 75.6% | 37.1% |
| EPS (diluted) | — | $-0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $86.6M | $61.6M | ||
| Q3 25 | $57.2M | $61.3M | ||
| Q2 25 | $53.1M | $61.1M | ||
| Q1 25 | $58.0M | $52.4M | ||
| Q4 24 | $46.3M | $52.7M | ||
| Q3 24 | $51.8M | $54.6M | ||
| Q2 24 | $49.5M | $52.8M | ||
| Q1 24 | $50.8M | $44.7M |
| Q4 25 | $-13.1M | $-10.1M | ||
| Q3 25 | $-84.1M | $-11.8M | ||
| Q2 25 | $-24.4M | $-7.1M | ||
| Q1 25 | $1.9M | $-10.7M | ||
| Q4 24 | $-53.8M | $-16.1M | ||
| Q3 24 | $-72.5M | $-7.9M | ||
| Q2 24 | $-6.4M | $-6.0M | ||
| Q1 24 | $29.7M | $-7.8M |
| Q4 25 | — | 73.2% | ||
| Q3 25 | — | 73.9% | ||
| Q2 25 | — | 72.1% | ||
| Q1 25 | — | 73.0% | ||
| Q4 24 | — | 67.5% | ||
| Q3 24 | — | 73.4% | ||
| Q2 24 | — | 77.3% | ||
| Q1 24 | — | 72.0% |
| Q4 25 | -2.1% | -13.3% | ||
| Q3 25 | -49.8% | -15.4% | ||
| Q2 25 | -56.7% | -17.4% | ||
| Q1 25 | -23.3% | -21.0% | ||
| Q4 24 | -42.7% | -26.7% | ||
| Q3 24 | -18.4% | -10.2% | ||
| Q2 24 | -30.2% | -10.7% | ||
| Q1 24 | -28.9% | -21.8% |
| Q4 25 | -15.1% | -16.4% | ||
| Q3 25 | -147.0% | -19.2% | ||
| Q2 25 | -45.9% | -11.6% | ||
| Q1 25 | 3.3% | -20.3% | ||
| Q4 24 | -116.1% | -30.5% | ||
| Q3 24 | -140.0% | -14.5% | ||
| Q2 24 | -12.9% | -11.4% | ||
| Q1 24 | 58.4% | -17.5% |
| Q4 25 | — | $-0.43 | ||
| Q3 25 | — | $-0.50 | ||
| Q2 25 | $-0.33 | $-0.30 | ||
| Q1 25 | $-0.04 | $-0.46 | ||
| Q4 24 | $-0.71 | $-0.70 | ||
| Q3 24 | $-0.88 | $-0.34 | ||
| Q2 24 | $-0.18 | $-0.26 | ||
| Q1 24 | $0.18 | $-0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.2M | $60.9M |
| Total DebtLower is stronger | $883.0K | $106.0M |
| Stockholders' EquityBook value | $600.1M | $346.6M |
| Total Assets | $1.2B | $508.6M |
| Debt / EquityLower = less leverage | 0.00× | 0.31× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $41.2M | $60.9M | ||
| Q3 25 | $35.8M | $57.7M | ||
| Q2 25 | $42.4M | $70.1M | ||
| Q1 25 | $52.8M | $58.8M | ||
| Q4 24 | $64.4M | $68.8M | ||
| Q3 24 | $220.6M | $76.1M | ||
| Q2 24 | $60.0M | $28.9M | ||
| Q1 24 | $134.2M | $47.7M |
| Q4 25 | $883.0K | $106.0M | ||
| Q3 25 | $586.0K | $105.3M | ||
| Q2 25 | $673.0K | $102.7M | ||
| Q1 25 | — | $77.4M | ||
| Q4 24 | $0 | $77.5M | ||
| Q3 24 | $128.4M | $76.9M | ||
| Q2 24 | $164.0M | $11.2M | ||
| Q1 24 | $183.7M | $11.3M |
| Q4 25 | $600.1M | $346.6M | ||
| Q3 25 | $607.2M | $349.3M | ||
| Q2 25 | $685.4M | $355.5M | ||
| Q1 25 | $665.2M | $347.1M | ||
| Q4 24 | $658.4M | $354.6M | ||
| Q3 24 | $707.0M | $370.9M | ||
| Q2 24 | $540.2M | $371.3M | ||
| Q1 24 | $510.9M | $370.6M |
| Q4 25 | $1.2B | $508.6M | ||
| Q3 25 | $1.2B | $493.5M | ||
| Q2 25 | $1.2B | $503.6M | ||
| Q1 25 | $1.2B | $470.3M | ||
| Q4 24 | $1.3B | $473.2M | ||
| Q3 24 | $1.4B | $489.3M | ||
| Q2 24 | $1.3B | $430.8M | ||
| Q1 24 | $1.3B | $437.2M |
| Q4 25 | 0.00× | 0.31× | ||
| Q3 25 | 0.00× | 0.30× | ||
| Q2 25 | 0.00× | 0.29× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | 0.00× | 0.22× | ||
| Q3 24 | 0.18× | 0.21× | ||
| Q2 24 | 0.30× | 0.03× | ||
| Q1 24 | 0.36× | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-51.4M | $10.3M |
| Free Cash FlowOCF − Capex | $-52.2M | $9.7M |
| FCF MarginFCF / Revenue | -60.3% | 15.8% |
| Capex IntensityCapex / Revenue | 0.9% | 1.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-16.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-51.4M | $10.3M | ||
| Q3 25 | $-53.5M | $-581.0K | ||
| Q2 25 | $-19.9M | $-10.5M | ||
| Q1 25 | $-30.2M | $-4.2M | ||
| Q4 24 | $-50.7M | $-4.0M | ||
| Q3 24 | $-4.9M | $-10.3M | ||
| Q2 24 | $-30.2M | $-6.1M | ||
| Q1 24 | $-15.5M | $-6.7M |
| Q4 25 | $-52.2M | $9.7M | ||
| Q3 25 | — | $-3.4M | ||
| Q2 25 | $-20.0M | $-13.9M | ||
| Q1 25 | $-31.0M | $-8.4M | ||
| Q4 24 | $-58.2M | $-4.2M | ||
| Q3 24 | $-9.4M | $-11.7M | ||
| Q2 24 | $-31.2M | $-12.8M | ||
| Q1 24 | $-15.7M | $-13.2M |
| Q4 25 | -60.3% | 15.8% | ||
| Q3 25 | — | -5.6% | ||
| Q2 25 | -37.6% | -22.8% | ||
| Q1 25 | -53.4% | -16.0% | ||
| Q4 24 | -125.7% | -8.1% | ||
| Q3 24 | -18.2% | -21.4% | ||
| Q2 24 | -63.2% | -24.2% | ||
| Q1 24 | -30.9% | -29.4% |
| Q4 25 | 0.9% | 1.0% | ||
| Q3 25 | 0.0% | 4.6% | ||
| Q2 25 | 0.0% | 5.6% | ||
| Q1 25 | 1.3% | 8.1% | ||
| Q4 24 | 16.3% | 0.5% | ||
| Q3 24 | 8.7% | 2.5% | ||
| Q2 24 | 2.2% | 12.7% | ||
| Q1 24 | 0.4% | 14.5% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -15.80× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.52× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ALTI
| Management Advisory Fees | $51.1M | 59% |
| Other | $32.7M | 38% |
| Distributions From Investments | $2.9M | 3% |
KIDS
Segment breakdown not available.
